US accuses Regeneron of fraudulent price reporting for eye drug

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. USO
3. NVDA
4. QQQ
5. INTC
6. ON
7. JPM
8. LEN
9. TLT
10. AMZN

Go back to US accuses Regeneron of fraudulent price reporting for eye drug
Regeneron (NASDAQ: REGN) Delayed: 774.61 +0.50 (0.06%)
Previous Close $774.11    52 Week High $592.36 
Open $775.82    52 Week Low $325.35 
Day High $779.98    P/E 203.31 
Day Low $771.80    EPS $3.81 
Volume 382,937